Researchers from the Duke University have found that an FDA-approved drug developed to treat cancer helps fight tuberculosis. The drug is an MMP inhibitor designed to increase the structural integrity of blood vessels in tumors so that other drugs can reach inside them. It performs the same function in the granulomas associated with tuberculosis so that antibiotics can reach the bacteria sheltering within.
For some blood transfusion patients, it is particularly difficult to find a compatible blood donor. Growing matching blood cells in the laboratory has long been an overarching goal of scientists for these patients.
Patients with a rare medical condition can receive life-saving treatment at the touch of a button thanks to a new device developed by scientists.Researchers at Newcastle University, UK, have developed a device.
Alexion Pharmaceuticals Inc said on Thursday its experimental drug to treat patients with the rare blood disorder, paroxysmal nocturnal hemoglobinuria (PNH), was shown to be not inferior to its flagship drug.
According to the study, researchers studied the role of phosphatidylinositol 4-phosphate (PI4P), a critical host factor for both encephalomyocarditis virus replication that has been recently found to expedite enterovirus replication organelles (RO) formation rather than being strictly required
Scientists at New Curtin University studied almost 10,000 men who had undergone vasectomy reversals across the globe has found no evidence of a link between the procedure and prostate cancer
Marine polyphenol phlorotannins promote sleep through the benzodiazepine site of the gamma-aminobutyric acid type A (GABAA) receptors. In this study, the sleep-promoting effects of triphlorethol A were investigated.
When a routine physical revealed mildly elevated blood-sugar levels, Michael Phillips was strongly encouraged to sign up for a diabetes self-management class. Phillips never asked about the cost of the two half-day sessions he attended in a conference room.
Researchers from UCLA and several other institutions found surgeries performed by older surgeons, age 50 and above have reported having lower patient mortality rates than those performed by younger surgeons.
Two US Food and Drug Administration (FDA) panels today jointly voted by a large margin that the cardiovascular (CV) safety of celecoxib (Celebrex, Pfizer) has been comparable to naproxen and ibuprofen.
New research, led by Western Sydney University, has found that public hospitals are not adequately resourced to treat the one million adults who currently live with clinically severe obesity in Australia.
Melbourne researchers have discovered that the 'odd one out' in a family of proteins known to drive cancer development prevents stomach cancer. The team showed switching off a gene called NF-κB1 caused the spontaneous development of stomach cancers.